Nucleus Arthroplasty™ motion preservation technology has vast market expanding opportunities, including failed conservative treatment and patients with early degenerative disc disease (DDD). This technology will be used to treat a patient population that is currently either under-treated by ineffective conservative treatment and discectomy or over-treated with fusion surgery or Total Disc Replacement (TDR).

Nucleus Arthroplasty non-fusion technology goes beyond nucleus replacement and involves a comprehensive systematic approach to DDD. It is not only the implant that is important in Nucleus Arthroplasty motion preservation procedures, but the consideration of many factors including proper patient selection, indications, surgical technique/approach, and post-operative rehabilitation. Nucleus Arthroplasty motion preservation technology involves a complete spectrum of treatment. The systematic approach of Nucleus Arthroplasty motion preservation technology is better suited to providing predictable and successful outcomes than the device-only approach of nucleus replacement.

Raymedica is actively pursuing additional spinal disc repair product offerings under its Total Nucleus Arthroplasty System™, Minimally Invasive Nucleus Arthroplasty System ™, and Less Invasive Nucleus Arthroplasty System ™ trademarks.

Nucleus Arthroplasty™ in Spinal Care is a four-book series that provides valuable guidance to spine surgeons and industry professionals as they seek to provide more effective and less invasive options for the treatment of DDD. This educational series on Nucleus Arthroplasty motion preservation technology can be used individually or collectively.
Volume I - Fundamentals; Volume II - Biomechanics & Development; Volume III - Surgical Techniques & Technology; and Volume IV - Emerging Technology are available for download at www.nucleusarthroplasty.com